$ACOR Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ACORDA THERAPEUTICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ACORDA THERAPEUTICS INC. Get notifications about new insider transactions in ACORDA THERAPEUTICS INC for free.
Page: < prev 1 ... 7 8 9 10 11 12 13 14 15 ... 17 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 11 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 20.56 | 700 | 14,392 | 146,784 | 147.5 K to 146.8 K (-0.47 %) |
| Dec 11 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 20.57 | 300 | 6,171 | 147,484 | 147.8 K to 147.5 K (-0.20 %) |
| Dec 11 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 20.66 | 500 | 10,330 | 147,784 | 148.3 K to 147.8 K (-0.34 %) |
| Dec 11 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 20.73 | 100 | 2,073 | 148,284 | 148.4 K to 148.3 K (-0.07 %) |
| Nov 23 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 17.00 | 250 | 4,250 | 8,030 | 8.3 K to 8 K (-3.02 %) |
| Nov 23 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 17.15 | 503 | 8,626 | 8,280 | 8.8 K to 8.3 K (-5.73 %) |
| Nov 23 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 17.30 | 250 | 4,325 | 8,783 | 9 K to 8.8 K (-2.77 %) |
| Nov 15 2007 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 18.10 | 600 | 10,860 | 35,374 | 36 K to 35.4 K (-1.67 %) |
| Nov 15 2007 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 18.15 | 268 | 4,864 | 35,974 | 36.2 K to 36 K (-0.74 %) |
| Nov 15 2007 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 18.16 | 32 | 581 | 36,242 | 36.3 K to 36.2 K (-0.09 %) |
| Nov 15 2007 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 18.24 | 369 | 6,731 | 36,274 | 36.6 K to 36.3 K (-1.01 %) |
| Nov 15 2007 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 18.25 | 500 | 9,125 | 36,643 | 37.1 K to 36.6 K (-1.35 %) |
| Nov 15 2007 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 18.28 | 200 | 3,656 | 37,143 | 37.3 K to 37.1 K (-0.54 %) |
| Nov 15 2007 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 18.29 | 300 | 5,487 | 37,343 | 37.6 K to 37.3 K (-0.80 %) |
| Nov 15 2007 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 18.30 | 101 | 1,848 | 37,643 | 37.7 K to 37.6 K (-0.27 %) |
| Nov 15 2007 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 18.35 | 1,000 | 18,350 | 37,744 | 38.7 K to 37.7 K (-2.58 %) |
| Nov 15 2007 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 18.40 | 800 | 14,720 | 38,744 | 39.5 K to 38.7 K (-2.02 %) |
| Nov 15 2007 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 18.45 | 1,695 | 31,273 | 39,544 | 41.2 K to 39.5 K (-4.11 %) |
| Nov 13 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 18.57 | 500 | 9,285 | 20,864 | 21.4 K to 20.9 K (-2.34 %) |
| Nov 13 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 18.63 | 500 | 9,315 | 21,364 | 21.9 K to 21.4 K (-2.29 %) |
| Nov 13 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 18.85 | 825 | 15,551 | 21,864 | 22.7 K to 21.9 K (-3.64 %) |
| Nov 13 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 19.00 | 600 | 11,400 | 22,689 | 23.3 K to 22.7 K (-2.58 %) |
| Oct 25 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 19.95 | 100 | 1,995 | 9,033 | 9.1 K to 9 K (-1.09 %) |
| Oct 25 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 20.00 | 200 | 4,000 | 9,133 | 9.3 K to 9.1 K (-2.14 %) |
| Oct 25 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 20.05 | 104 | 2,085 | 9,333 | 9.4 K to 9.3 K (-1.10 %) |
| Oct 25 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 20.10 | 100 | 2,010 | 9,437 | 9.5 K to 9.4 K (-1.05 %) |
| Oct 25 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 20.15 | 100 | 2,015 | 9,537 | 9.6 K to 9.5 K (-1.04 %) |
| Oct 25 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 20.20 | 100 | 2,020 | 9,637 | 9.7 K to 9.6 K (-1.03 %) |
| Oct 25 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 20.25 | 200 | 4,050 | 9,737 | 9.9 K to 9.7 K (-2.01 %) |
| Oct 25 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 20.35 | 100 | 2,035 | 9,937 | 10 K to 9.9 K (-1.00 %) |
| Oct 25 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 19.95 | 240 | 4,788 | 23,289 | 23.5 K to 23.3 K (-1.02 %) |
| Oct 25 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 20.00 | 480 | 9,600 | 23,529 | 24 K to 23.5 K (-2.00 %) |
| Oct 25 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 20.05 | 265 | 5,313 | 24,009 | 24.3 K to 24 K (-1.09 %) |
| Oct 25 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 20.10 | 240 | 4,824 | 24,274 | 24.5 K to 24.3 K (-0.98 %) |
| Oct 25 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 20.15 | 240 | 4,836 | 24,514 | 24.8 K to 24.5 K (-0.97 %) |
| Oct 25 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 20.20 | 240 | 4,848 | 24,754 | 25 K to 24.8 K (-0.96 %) |
| Oct 25 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 20.25 | 480 | 9,720 | 24,994 | 25.5 K to 25 K (-1.88 %) |
| Oct 25 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 20.35 | 240 | 4,884 | 25,474 | 25.7 K to 25.5 K (-0.93 %) |
| Oct 16 2007 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Option Exercise | M | 2.60 | 1,923 | 5,000 | 0 | |
| Oct 16 2007 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Option Exercise | M | 2.60 | 2,564 | 6,666 | 0 | |
| Oct 16 2007 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 19.91 | 200 | 3,982 | 41,239 | 41.4 K to 41.2 K (-0.48 %) |
| Oct 16 2007 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 19.92 | 100 | 1,992 | 41,439 | 41.5 K to 41.4 K (-0.24 %) |
| Oct 16 2007 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 20.06 | 300 | 6,018 | 41,539 | 41.8 K to 41.5 K (-0.72 %) |
| Oct 16 2007 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 20.09 | 74 | 1,487 | 41,839 | 41.9 K to 41.8 K (-0.18 %) |
| Oct 16 2007 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 20.10 | 300 | 6,030 | 41,913 | 42.2 K to 41.9 K (-0.71 %) |
| Oct 16 2007 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 20.11 | 292 | 5,872 | 42,213 | 42.5 K to 42.2 K (-0.69 %) |
| Oct 16 2007 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 20.17 | 300 | 6,051 | 42,505 | 42.8 K to 42.5 K (-0.70 %) |
| Oct 16 2007 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 20.18 | 300 | 6,054 | 42,805 | 43.1 K to 42.8 K (-0.70 %) |
| Oct 16 2007 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 20.33 | 100 | 2,033 | 43,105 | 43.2 K to 43.1 K (-0.23 %) |
| Oct 16 2007 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 20.34 | 155 | 3,153 | 43,205 | 43.4 K to 43.2 K (-0.36 %) |
| Oct 16 2007 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 20.37 | 245 | 4,991 | 43,360 | 43.6 K to 43.4 K (-0.56 %) |
| Oct 16 2007 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 20.40 | 100 | 2,040 | 43,605 | 43.7 K to 43.6 K (-0.23 %) |
| Oct 16 2007 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 20.46 | 300 | 6,138 | 43,705 | 44 K to 43.7 K (-0.68 %) |
| Oct 16 2007 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 20.49 | 300 | 6,147 | 44,005 | 44.3 K to 44 K (-0.68 %) |
| Oct 16 2007 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 20.70 | 300 | 6,210 | 44,305 | 44.6 K to 44.3 K (-0.67 %) |
| Oct 16 2007 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Buy | M | 2.60 | 4,487 | 11,666 | 44,605 | 40.1 K to 44.6 K (+11.18 %) |
| Sep 27 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 18.56 | 200 | 3,712 | 10,037 | 10.2 K to 10 K (-1.95 %) |
| Sep 27 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 18.60 | 200 | 3,720 | 10,237 | 10.4 K to 10.2 K (-1.92 %) |
| Sep 27 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 18.62 | 200 | 3,724 | 10,437 | 10.6 K to 10.4 K (-1.88 %) |
| Sep 27 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 18.70 | 100 | 1,870 | 10,637 | 10.7 K to 10.6 K (-0.93 %) |
| Sep 27 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 18.71 | 100 | 1,871 | 10,737 | 10.8 K to 10.7 K (-0.92 %) |
| Sep 27 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 18.76 | 200 | 3,752 | 10,837 | 11 K to 10.8 K (-1.81 %) |
| Sep 27 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 18.81 | 408 | 7,674 | 11,037 | 11.4 K to 11 K (-3.56 %) |
| Sep 27 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 18.85 | 200 | 3,770 | 11,445 | 11.6 K to 11.4 K (-1.72 %) |
| Sep 27 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 19.00 | 200 | 3,800 | 11,645 | 11.8 K to 11.6 K (-1.69 %) |
| Sep 27 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 19.05 | 200 | 3,810 | 11,845 | 12 K to 11.8 K (-1.66 %) |
| Sep 27 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 18.56 | 200 | 3,712 | 25,714 | 25.9 K to 25.7 K (-0.77 %) |
| Sep 27 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 18.60 | 200 | 3,720 | 25,914 | 26.1 K to 25.9 K (-0.77 %) |
| Sep 27 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 18.64 | 200 | 3,728 | 26,114 | 26.3 K to 26.1 K (-0.76 %) |
| Sep 27 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 18.70 | 200 | 3,740 | 26,314 | 26.5 K to 26.3 K (-0.75 %) |
| Sep 27 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 18.75 | 250 | 4,688 | 26,514 | 26.8 K to 26.5 K (-0.93 %) |
| Sep 27 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 18.81 | 375 | 7,054 | 26,764 | 27.1 K to 26.8 K (-1.38 %) |
| Sep 27 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 18.82 | 100 | 1,882 | 27,139 | 27.2 K to 27.1 K (-0.37 %) |
| Sep 27 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 18.83 | 100 | 1,883 | 27,239 | 27.3 K to 27.2 K (-0.37 %) |
| Sep 27 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 18.85 | 100 | 1,885 | 27,339 | 27.4 K to 27.3 K (-0.36 %) |
| Sep 27 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 18.86 | 150 | 2,829 | 27,439 | 27.6 K to 27.4 K (-0.54 %) |
| Sep 27 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 19.00 | 300 | 5,700 | 27,589 | 27.9 K to 27.6 K (-1.08 %) |
| Sep 27 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 19.05 | 250 | 4,763 | 27,889 | 28.1 K to 27.9 K (-0.89 %) |
| Sep 12 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 15.91 | 100 | 1,591 | 12,045 | 12.1 K to 12 K (-0.82 %) |
| Sep 12 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 15.94 | 168 | 2,678 | 12,145 | 12.3 K to 12.1 K (-1.36 %) |
| Sep 12 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 15.96 | 427 | 6,815 | 12,313 | 12.7 K to 12.3 K (-3.35 %) |
| Sep 12 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 15.97 | 200 | 3,194 | 12,740 | 12.9 K to 12.7 K (-1.55 %) |
| Sep 12 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 16.00 | 400 | 6,400 | 12,940 | 13.3 K to 12.9 K (-3.00 %) |
| Sep 12 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 16.01 | 312 | 4,995 | 13,340 | 13.7 K to 13.3 K (-2.29 %) |
| Sep 12 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 16.03 | 200 | 3,206 | 13,652 | 13.9 K to 13.7 K (-1.44 %) |
| Sep 12 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 16.04 | 200 | 3,208 | 13,852 | 14.1 K to 13.9 K (-1.42 %) |
| Sep 12 2007 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 15.89 | 200 | 3,178 | 40,118 | 40.3 K to 40.1 K (-0.50 %) |
| Sep 12 2007 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 15.90 | 200 | 3,180 | 40,318 | 40.5 K to 40.3 K (-0.49 %) |
| Sep 12 2007 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 15.96 | 800 | 12,768 | 40,518 | 41.3 K to 40.5 K (-1.94 %) |
| Sep 12 2007 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 15.98 | 400 | 6,392 | 41,318 | 41.7 K to 41.3 K (-0.96 %) |
| Sep 12 2007 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 16.00 | 300 | 4,800 | 41,718 | 42 K to 41.7 K (-0.71 %) |
| Sep 12 2007 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 16.05 | 458 | 7,351 | 42,018 | 42.5 K to 42 K (-1.08 %) |
| Sep 12 2007 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 16.06 | 400 | 6,424 | 42,476 | 42.9 K to 42.5 K (-0.93 %) |
| Sep 12 2007 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 16.07 | 342 | 5,496 | 42,876 | 43.2 K to 42.9 K (-0.79 %) |
| Sep 12 2007 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 16.09 | 100 | 1,609 | 43,218 | 43.3 K to 43.2 K (-0.23 %) |
| Sep 12 2007 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 16.48 | 800 | 13,184 | 43,318 | 44.1 K to 43.3 K (-1.81 %) |
| Sep 12 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 15.93 | 500 | 7,965 | 148,384 | 148.9 K to 148.4 K (-0.34 %) |
| Sep 12 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 15.97 | 500 | 7,985 | 148,884 | 149.4 K to 148.9 K (-0.33 %) |
| Sep 12 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 15.98 | 500 | 7,990 | 149,384 | 149.9 K to 149.4 K (-0.33 %) |
| Sep 12 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 16.00 | 1,162 | 18,592 | 149,884 | 151 K to 149.9 K (-0.77 %) |
| Sep 12 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 16.03 | 1,000 | 16,030 | 151,046 | 152 K to 151 K (-0.66 %) |
| Sep 12 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 16.08 | 900 | 14,472 | 152,046 | 152.9 K to 152 K (-0.59 %) |
| Sep 12 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 16.09 | 938 | 15,092 | 152,946 | 153.9 K to 152.9 K (-0.61 %) |
| Sep 12 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 16.11 | 100 | 1,611 | 153,884 | 154 K to 153.9 K (-0.06 %) |
| Sep 12 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 16.16 | 300 | 4,848 | 153,984 | 154.3 K to 154 K (-0.19 %) |
| Sep 12 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 16.28 | 500 | 8,140 | 154,284 | 154.8 K to 154.3 K (-0.32 %) |
| Sep 12 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 16.45 | 100 | 1,645 | 154,784 | 154.9 K to 154.8 K (-0.06 %) |
| Sep 12 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 16.48 | 1,000 | 16,480 | 154,884 | 155.9 K to 154.9 K (-0.64 %) |
| Sep 12 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 16.51 | 500 | 8,255 | 155,884 | 156.4 K to 155.9 K (-0.32 %) |
| Aug 20 2007 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Option Exercise | M | 2.60 | 6,410 | 16,666 | 0 | |
| Aug 20 2007 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 18.00 | 2,444 | 43,992 | 44,118 | 46.6 K to 44.1 K (-5.25 %) |
| Aug 20 2007 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 18.10 | 600 | 10,860 | 46,562 | 47.2 K to 46.6 K (-1.27 %) |
| Aug 20 2007 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Buy | M | 2.60 | 6,410 | 16,666 | 47,162 | 40.8 K to 47.2 K (+15.73 %) |
| Aug 14 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 16.73 | 844 | 14,120 | 156,384 | 157.2 K to 156.4 K (-0.54 %) |
| Aug 14 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 16.77 | 200 | 3,354 | 157,228 | 157.4 K to 157.2 K (-0.13 %) |
| Aug 14 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 16.80 | 400 | 6,720 | 157,428 | 157.8 K to 157.4 K (-0.25 %) |
| Aug 14 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 16.84 | 981 | 16,520 | 157,828 | 158.8 K to 157.8 K (-0.62 %) |
| Aug 14 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 16.85 | 19 | 320 | 158,809 | 158.8 K to 158.8 K (-0.01 %) |
| Aug 14 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 16.86 | 2,400 | 40,464 | 158,828 | 161.2 K to 158.8 K (-1.49 %) |
| Aug 14 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 16.87 | 2,156 | 36,372 | 161,228 | 163.4 K to 161.2 K (-1.32 %) |
| Aug 14 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 16.90 | 400 | 6,760 | 163,384 | 163.8 K to 163.4 K (-0.24 %) |
| Aug 14 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 16.91 | 100 | 1,691 | 163,784 | 163.9 K to 163.8 K (-0.06 %) |
| Aug 14 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 16.92 | 600 | 10,152 | 163,884 | 164.5 K to 163.9 K (-0.36 %) |
| Aug 14 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 16.93 | 300 | 5,079 | 164,484 | 164.8 K to 164.5 K (-0.18 %) |
| Aug 14 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 16.94 | 100 | 1,694 | 164,784 | 164.9 K to 164.8 K (-0.06 %) |
| Aug 14 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 16.95 | 1,000 | 16,950 | 164,884 | 165.9 K to 164.9 K (-0.60 %) |
| Aug 14 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 16.96 | 1,614 | 27,373 | 165,884 | 167.5 K to 165.9 K (-0.96 %) |
| Aug 14 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 16.97 | 2,373 | 40,270 | 167,498 | 169.9 K to 167.5 K (-1.40 %) |
| Aug 14 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 16.98 | 100 | 1,698 | 169,871 | 170 K to 169.9 K (-0.06 %) |
| Aug 14 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 16.99 | 2,400 | 40,776 | 169,971 | 172.4 K to 170 K (-1.39 %) |
| Aug 14 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.00 | 1,600 | 27,200 | 172,371 | 174 K to 172.4 K (-0.92 %) |
| Aug 14 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.01 | 500 | 8,505 | 173,971 | 174.5 K to 174 K (-0.29 %) |
| Aug 14 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.02 | 900 | 15,318 | 174,471 | 175.4 K to 174.5 K (-0.51 %) |
| Aug 14 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.03 | 3,000 | 51,090 | 175,371 | 178.4 K to 175.4 K (-1.68 %) |
| Aug 14 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.04 | 1,000 | 17,040 | 178,371 | 179.4 K to 178.4 K (-0.56 %) |
| Aug 14 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.05 | 1,000 | 17,050 | 179,371 | 180.4 K to 179.4 K (-0.55 %) |
| Aug 14 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.08 | 2,000 | 34,160 | 180,371 | 182.4 K to 180.4 K (-1.10 %) |
| Aug 14 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.23 | 13 | 224 | 182,371 | 182.4 K to 182.4 K (-0.01 %) |
| Aug 14 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 16.24 | 292 | 4,742 | 182,384 | 182.7 K to 182.4 K (-0.16 %) |
| Aug 14 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 16.27 | 1,500 | 24,405 | 182,676 | 184.2 K to 182.7 K (-0.81 %) |
| Aug 14 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 16.33 | 900 | 14,697 | 184,176 | 185.1 K to 184.2 K (-0.49 %) |
| Aug 14 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 16.34 | 300 | 4,902 | 185,076 | 185.4 K to 185.1 K (-0.16 %) |
| Aug 14 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 16.38 | 200 | 3,276 | 185,376 | 185.6 K to 185.4 K (-0.11 %) |
| Aug 14 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 16.39 | 335 | 5,491 | 185,576 | 185.9 K to 185.6 K (-0.18 %) |
| Aug 14 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 16.50 | 900 | 14,850 | 185,911 | 186.8 K to 185.9 K (-0.48 %) |
| Aug 14 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 16.51 | 900 | 14,859 | 186,811 | 187.7 K to 186.8 K (-0.48 %) |
| Aug 14 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 16.55 | 900 | 14,895 | 187,711 | 188.6 K to 187.7 K (-0.48 %) |
| Aug 14 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 16.58 | 310 | 5,140 | 188,611 | 188.9 K to 188.6 K (-0.16 %) |
| Aug 14 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 16.60 | 590 | 9,794 | 188,921 | 189.5 K to 188.9 K (-0.31 %) |
| Aug 14 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 16.63 | 520 | 8,648 | 189,511 | 190 K to 189.5 K (-0.27 %) |